250 related articles for article (PubMed ID: 9818873)
1. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease.
Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM
Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873
[TBL] [Abstract][Full Text] [Related]
2. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
[TBL] [Abstract][Full Text] [Related]
3. Neonatal seizures and severe hypotonia in a male infant suffering from a defect in peroxisomal beta-oxidation.
Van Maldergem L; Espeel M; Wanders RJ; Roels F; Gerard P; Scalais E; Mannaerts GP; Casteels M; Gillerot Y
Neuromuscul Disord; 1992; 2(3):217-24. PubMed ID: 1483048
[TBL] [Abstract][Full Text] [Related]
4. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
[TBL] [Abstract][Full Text] [Related]
5. A new type of peroxisomal disorder with variable expression in liver and fibroblasts.
Mandel H; Espeel M; Roels F; Sofer N; Luder A; Iancu TC; Aizin A; Berant M; Wanders RJ; Schutgens RB
J Pediatr; 1994 Oct; 125(4):549-55. PubMed ID: 7931872
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
7. Zellweger syndrome in a preterm, small for gestational age infant.
Samsom JF; Jakobs C; van de Klei-van Moorsel J; Smit LM; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1992; 15(1):75-83. PubMed ID: 1583879
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients.
Mihalik SJ; Moser HW; Watkins PA; Danks DM; Poulos A; Rhead WJ
Pediatr Res; 1989 May; 25(5):548-52. PubMed ID: 2717271
[TBL] [Abstract][Full Text] [Related]
9. Biochemical features of a patient with Zellweger-like syndrome with normal PTS-1 and PTS-2 peroxisomal protein import systems: a new peroxisomal disease.
Singh I; Voigt RG; Sheikh FG; Kremser K; Brown FR
Biochem Mol Med; 1997 Aug; 61(2):198-207. PubMed ID: 9259985
[TBL] [Abstract][Full Text] [Related]
10. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal bifunctional enzyme deficiency.
Watkins PA; Chen WW; Harris CJ; Hoefler G; Hoefler S; Blake DC; Balfe A; Kelley RI; Moser AB; Beard ME
J Clin Invest; 1989 Mar; 83(3):771-7. PubMed ID: 2921319
[TBL] [Abstract][Full Text] [Related]
12. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.
Poll-The BT; Saudubray JM; Ogier H; Schutgens RB; Wanders RJ; Schrakamp G; van den Bosch H; Trijbels JM; Poulos A; Moser HW
J Inherit Metab Dis; 1986; 9(2):169-74. PubMed ID: 2427795
[TBL] [Abstract][Full Text] [Related]
13. Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder.
Gootjes J; Skovby F; Christensen E; Wanders RJ; Ferdinandusse S
Neurology; 2004 Jun; 62(11):2077-81. PubMed ID: 15184617
[TBL] [Abstract][Full Text] [Related]
14. [Peroxisomal disorders in neurology].
Orii T; Hashimoto T
No To Hattatsu; 1992 Mar; 24(2):174-5. PubMed ID: 1567653
[TBL] [Abstract][Full Text] [Related]
15. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes.
Stanczak H; Kremser K; Singh AK; Ashcraft J; Stanley W; Singh I
Hum Hered; 1992; 42(3):172-8. PubMed ID: 1511996
[TBL] [Abstract][Full Text] [Related]
16. Accumulation and impaired in vivo metabolism of di- and trihydroxycholestanoic acid in two patients.
Wanders RJ; Casteels M; Mannaerts GP; van Roermund CW; Schutgens RB; Kozich V; Zeman J; Hyanek J
Clin Chim Acta; 1991 Oct; 202(3):123-32. PubMed ID: 1839974
[TBL] [Abstract][Full Text] [Related]
17. Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.
Mandel H; Berant M; Aizin A; Gershony R; Hemmli S; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1992; 15(3):381-4. PubMed ID: 1405475
[No Abstract] [Full Text] [Related]
18. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients.
Shimozawa N; Suzuki Y; Tomatsu S; Tsukamoto T; Osumi T; Fujiki Y; Kamijo K; Hashimoto T; Kondo N; Orii T
Pediatr Res; 1996 May; 39(5):812-5. PubMed ID: 8726233
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome mosaicism in the livers of peroxisomal deficiency patients.
Espeel M; Mandel H; Poggi F; Smeitink JA; Wanders RJ; Kerckaert I; Schutgens RB; Saudubray JM; Poll-The BT; Roels F
Hepatology; 1995 Aug; 22(2):497-504. PubMed ID: 7635418
[TBL] [Abstract][Full Text] [Related]
20. Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.
McGuinness MC; Moser AB; Poll-The BT; Watkins PA
Biochem Med Metab Biol; 1993 Apr; 49(2):228-42. PubMed ID: 8484962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
